Skip to main content Accessibility help
×
Home
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 1
  • Print publication year: 2004
  • Online publication date: July 2009

24 - Lesch–Nyhan syndrome

Summary

Introduction

Lesch–Nyhan disease, the most common and most thoroughly studied of the disorders of purine metabolism, was first described as a syndrome in 1964 (Lesch & Nyhan, 1964). The initial two patients were brothers, an early indication of the X-linked recessive nature of the disease, which shortly became evident with the study of the pedigrees of families with numbers of affected males (Nyhan et al., 1967). The older brother of the proband was in an institution with a diagnosis of mental retardation and cerebral palsy, when the younger brother was admitted with hematuria and found to have hyperuricemia and uricosuria and had bizarre and compulsive, self-mutilative biting. Both brothers exhibited involuntary choreoathetoid movements. A hallmark feature of the disease has continued to be loss of tissue resulting from biting or some other form of self-injurious behavior. Biochemical studies identified that the uric acid pool was enlarged and its turnover was abnormally rapid. The overproduction of purine from an intravenous glycine precursor was 20 times the normal value (Nyhan, 1968), whereas in adults with gouty arthritis the greatest rates of de novo synthesis of purines observed were twice the normal value.

The molecular defect is the virtually complete absence of activity of the enzyme hypoxanthine guanine phosphoribosyl transferase (HPRT) (Fig. 24.1) (Seegmiller et al., 1967). HPRT catalyzes the reaction in which the purine bases, hypoxanthine and guanine, are converted in what has been referred to as a salvage or reutilization pathway to their respective nucleotides, inosinic acid (IMP) and guanylic acid (GMP).

REFERENCES
Anderson, L., Dancis, J. & Alpert, M. (1978). Behavioral contingencies and self-mutilation in Lesch Nyhan disease. Journal of Consulting and Clinical Psychology, 46: 529–536
Arnold, W. J. & Kelley, W. N. (1971). Molecular basis of hypoxanthine guanine phosphoribosyltransferase purification and subunit structure. Journal of Biological Chemistry, 246: 7398–7404
Bakay, B., Nyhan, W. L., Fawcett, N. & Kogut, M. D. (1972). Isoenzymes of hypoxanthine–guanine phosphoribosyl transferase in a family with partial deficiency of the enzyme. Biochemical Genetics, 7: 73–85
Bakay, B., Becker, M. A. & Nyhan, W. L. (1976). Reaction of antibody to normal human hypoxanthine phosphoribosyltransferase with products of mutant genes. Archives of Biochemistry Biophysics, 177: 415–426
Bakay, B., Francke, U., Nyhan, W. L. & Seegmiller, J. E. (1977). Experience with detection of heterozygous carriers and prenatal diagnosis of Lesch–Nyhan disease. In Purine Metabolism in Man II: Regulation of Pathways and Enzyme Defects, ed. M. M. Muller, E. Kaiser & J. E. Seegmiller, pp. 351–358. New York: Plenum Press
Bakay, B., Nissinen, E. & Sweetman, L. (1978a).Analysis of radioactive and nonradioactive purine bases, nucleosides, nucleotides by high-speed chromatography on a single column. Annals of Biochemistry, 86: 65–77
Bakay, B., Nissinen, E. A., Sweetman, L. & Nyhan, W. L. (1978b). Analysis of radioactive and nonradioactive purine bases, purine nucleosides and purine nucleotides by high-speed chromatography on a single column. Monographs of Human Genetics, pp. 127–134. Basel: Karger
Bakay, B., Nissinen, E., Sweetman, L., Francke, U. & Nyhan, W. L. (1979). Utilization of purines by an HPRT variant in an intelligent, nonmutilative patient with features of the Lesch–Nyhan syndrome. Pediatric Research, 13: 1365–1370
Barabas, G. & Zumoff, P. J. (1993). Overview of Lesch–Nyhan disease. Matheny Bulletin Special Edition, 3: 1–10
Basserman, R., , Gutenson W. & Springman, J. S. (1979). Pathological and immunological observations in a case of Lesch–Nyhan syndrome. European Journal of Pediatrics, 132: 93–104
Brennad, J., Konecki, D. S. & Caskey, C. T. (1983). Expression of human and Chinese hamster hypoxanthine–guanine phosphoribosyltransferase cDNA recombinants in cultured Lesch–Nyhan and Chinese hamster fibroblasts. Journal of Biological Chemistry, 258: 9593–9596
Bull, M. & LaVecchio, F. (1978). Behavior therapy for a child with Lesch–Nyhan syndrome. Developmental and Medical Child Neurology, 20: 368–374
Catel, V. W. & Schmidt, J. (1959). Uber familiar gichtische Diathese in Verbinding mit zerebralen und renalen Symptomen bei einem Kleinkind. Deutsche Medicalische Wochenschrift, 84: 2145–2147
Chang, S. M., Wager-Smith, K., Tsao, T. Y. et al. (1987). Construction of a defective retrovirus containing the human hypoxanthine phosphoribosyl transferase cDNA and its expression in cultured cells and mouse bone marrow. Molecular and Cell Biology, 7: 854–863
Christie, R., Bay, C., Kaufman, I. A., Bakay, B., Borden, M. & Nyhan, W. L. (1982). Lesch–Nyhan disease: clinical experience with nineteen patients. Developmental and Medical Child Neurology, 24: 293–306
Crawhall, J. C., Henderson, J. F. & Kelley, W. N. (1972). Diagnosis and treatment of the Lesch–Nyhan syndrome. Pediatric Research, 6: 504–513
Crussi, F. G., Robertson, D. M. & Hiscox, J. L. (1969). The pathological condition of the Lesch–Nyhan syndrome. American Journal of Disease in Children, 118: 501–506
Davidson, B. L., Tarle, S. A., Antwerp, M. V. et al. (1991). Identification of 17 independent mutations responsible for human hypoxanthine–guanine phosphoribosyltransferase (HPRT) deficiency. American Journal of Human Genetics, 48: 951–958
Dizmang, L. H. & Cheatham, C. F. (1970). The Lesch–Nyhan syndrome. American Journal of Psychiatry, 127: 671–677
Duker, P. (1975). Behaviour control of self-biting in a Lesch–Nyhan patient. Journal of Mental Deficiency Research, 19: 11–19
Edwards, A., Voss, H., Rice, P. et al. (1990). Automated DNA sequencing of the human HPRT locus. Genomics, 6: 593–608
Emmerson, B. T. & Thompson, L. (1973). The spectrum of hypoxanthine guanine phosphoribosyltransferase deficiency. Quarterly Journal of Medicine, 166: 423–40
Emmerson, B. T. & Wyngaarden, J. B. (1969). Purine metabolism in heterozygous carriers of hypoxanthine–guanine phosphoribosyltransferase deficiency. Science, 166: 1533–1535
Fox, I. H. & Kelley, W. N. (1971). Phosphoribosylpyrophosphate in man: biochemical and clinical significance. Annals of Internal Medicine, 74: 424–433
Francke, U., Felsenstein, J., Gartler, S. M. et al. (1976). The occurrence of new mutants in the X-linked recessive Lesch-Nyhan disease. American Journal of Human Genetics, 28: 123–137
Frith, C. D., Johnstone, E. C., Joseph, M. H., Powell, R. J. & Watts, R. W. E. (1976). Double-blind clinical trial of 5-hydroxytryptophan in a case of Lesch–Nyhan syndrome. Journal of Neurology, Neurosurgery and Psychology, 39: 652–656
Gartler, S. M., Scott, R. C., Goldstein, J. L. & Campbell, B. (1971). Lesch–Nyhan syndrome: rapid detection of heterozygotes by the use of hair follicles. Science, 172: 572–574
Geerdink, R. A., Vries, W. H. M., Willemse, J., Oei, T. L. & Bruyn, C. H. M. M. (1973). An atypical case of hypoxanthine–guanine phosphoribosyltransferase deficiency (Lesch-Nyhan syndrome). Clinical Genetics, 4: 348–352
Gibbs, R. A., Nguyen, P., Edwards, A. et al. (1990). Multiplex DNA deletion detection and exon sequencing of the hypoxanthine phosphoribosyltransferase gene in Lesch–Nyhan families. Genomics, 7: 235–244
Gilbert, S., Spellacy, E. & Watts, R. W. E. (1979). Problems in the behavioral treatment of self-injury in the Lesch–Nyhan syndrome. Developmental and Medical Child Neurology, 21: 795–800
Gonzalez, T. (1968). Coreo-atetosis congenita y gota. Revue Clinica Espana, 109: 349–352
Gordon, R. B., Emmerson, B. I., Stout, J. T. & Caskey, C. T. (1987). Molecular studies of hypoxanthine–guanine phospho-ribosyltransferase mutations in six Australian families. Australian and New Zealand Journal of Medicine, 17: 424–429
Gottlieb, R. P., Koppel, M. M., Nyhan, W. L. et al. (1982). Hyperuricaemia and choreoathetosis in a child without mental retardation or self-mutilation – a new HPRT variant. Journal of Inherited Metabolic Disease, 5: 183–186
Gutenson, W. & Guroff, G. (1972). Hypoxanthine–guanine phosphoribosyltransferase from rat brain (purification kinetic properties, development and distribution). Journal of Neurochemistry, 19: 2139–2150
Harkness, R. A., McCreanor, G. M. & Watts, R. W. E. (1988). Lesch–Nyhan syndrome and its pathogenesis: purine concentrations in plasma and urine with metabolic profiles in CSF. Journal of Inherited Metabolic Disease, 11: 239–252
Harris, J. C., Lee, R. R., Jinnah, H. A., Wong, D. F., Yaster, M. & Bryan, R. N. (1998). Craniocerebral magnetic resonance imaging measurement and findings in Lesch–Nyhan syndrome. Archives of Neurology, 55: 547–553
Hoefnagel, D. (1968). Summary: pathology and pathologic physiology. Federation Proceedings, 28: 1042–1046
Jolly, D. H., Esty, A. C., Bernard, H. U. & Friedmann, T. (1982). Isolation of a genomic clone encoding human hypoxanthine guanine phosphoribosyl transferase. Proceedings of the National Academy of Sciences, USA, 79: 5038–5041
Jolly, D. J., Okayama, H., Berg, P. et al. (1983). Isolation and characterization of a full length, expressible cDNA for human hypoxanthine guanine phosphoribosyl transferase. Proceedings of the National Academy of Sciences, USA, 80: 477–479
Kaufman, J. M., Greene, M. L. & Seegmiller, J. E. (1968). Urine uric acid to creatinine ratio: screening test for disorders of purine metabolism. Journal of Pediatrics, 73: 583–592
Kelley, W. L., Greene, M. L., Rosenbloom, F. M. et al. (1969). Hypoxanthine–guanine phosphoribosyltransferase deficiency in gout: a review. Annals of Internal Medicine, 70: 155–206
Kim, S. H., Moores, J. C., David, D. et al. (1986). The organization of the human HPRT gene. Nucleic Acids Research, 14: 3103–3118
Kogut, M. D., Donnell, G. N., Nyhan, W. L. & Sweetman, L. (1970). Disorder of purine metabolism due to partial deficiency of hypoxanthine–guanine phosphoribosyltransferase. American Journal of Medicine, 48: 148–161
Landgrebe, A. R., Nyhan, W. L. & Coleman, M. (1975). Urinary-tract stones resulting from the excretion of oxypurinol. New England Journal of Medicine, 292: 626–627
Lesch, M. & Nyhan, W. L. (1964). A familial disorder of uric acid metabolism and central nervous system function. American Journal of Medicine, 36: 561–570
Letts, R. M. & Hobson, D. A. (1975). Special devices as in aids in the management of child self-mutilation in the Lesch–Nyhan syndrome. Pediatrics, 55: 853–855
Lloyd, K. G., Hornykiewicz, O., Davison, L. et al. (1981). Biochemical evidence of dysfunciton of brain neurotransmitters in the Lesch–Nyhan syndrome. New England Journal of Medicine, 305: 1106–1111
McDonald, J. A. & Kelley, W. N. (1972). Lesch–Nyhan syndrome: absence of the mutant enzyme in erythrocytes of a heterozygote for both normal and mutant hypoxanthineguanine phosphoribosyltransferase. Biochemical Genetics, 6: 21–26
Marcus, S., Steen, A-M., Andersson, B. et al. (1992). Mutation analysis and prenatal diagnosis in a Lesch–Nyhan family showing non-random X-inactivation interfering with carrier detection tests. Human Genetics, 89: 395–400
Marcus, S., Hellgren, D., Lambert, B. et al. (1993). Duplication in the hypoxanthine phosphoribosyl-transferase gene caused by Alu–Alu recombination in a patient with Lesch–Nyhan syndrome. Human Genetics, 90: 477–482
Nelson, D. L., Chang, S. M. W., Henkel-Tigges, J. et al. (1986). Gene replacement therapy for inborn errors of purine metabolism. Cold Spring Harbor Symposia for Quantitative Biology, 51: 1065–1071
Nieto, L. H., , Nyhan W. L., Page, T. et al. (1985). Sindrome de Lesch–Nyhan: nueva variante con actividad de hipoxantina-guanina fosforribosil transferasa (HPRT) superior a la de la enfermedad clasica y deteccion del rasgo heterocigoto en los hematies de la portadora. Medicina Clinic (Barcelona), 84: 68–71
Nyhan, W. L. (1968). Introduction – clinical features. In Seminars on the Lesch–Nyhan syndrome, ed. J. H. Bland Federal Proceedings, 27: 1027–1033
Nyhan, W. L. (1976). Behavior in the Lesch–Nyhan syndrome. Journal of Autism and Childhood Schizophrenia, 6: 235–252
Nyhan, W. L. (1977). Genetic heterogeneity at the locus for hypoxanthine–guanine phosphoribosyltransferase. In Purine and Pyrimidine Metabolism, Ciba Foundation Symposium 48 (London), pp. 65–81, Amsterdam: Elsevier/Medica/North Holland
Nyhan, W. L. (1994). The Lesch–Nyhan disease. In Destructive Behavior in Developmental Disabilities, Diagnosis and Treatment, ed. T. Thompson & D. B. Gray, pp. 181–197. Thousand Oaks, CA: Sage Publications
Nyhan, W. L. & Ozand, P. T. (1998). Lesch–Nyhan disease. In Atlas of Metabolic Diseases, pp. 376–388. London: Chapman & Hall
Nyhan, W. L. & Wong, D. F. (1996). New approaches to understanding Lesch–Nyhan disease. New England Journal of Medicine (Editorial), 334: 1602–1604
Nyhan, W. L., Pesek, J., Sweetman, L., Carpenter, D. G. & Carter, C. H. (1967). Genetics of an X-linked disorder of uric acid metabolism and cerebral function. Pediatric Research, 1: 5–13
Nyhan, W. L., Bakay, B., Connor, J. D. et al. (1970). Hemizygous expression of glucose-6-phosphate dehydrogenase in erythrocytes of heterozygotes for the Lesch–Nyhan syndrome. Proceedings of the National Academy of Sciences, USA, 65: 214–218
Nyhan, W. L., Johnson, H. G., Kaufman, I. A. & Jones, K. L. (1980). Serotonergic approaches to the modification of behavior in the Lesch–Nyhan syndrome. Applied Research in Mental Retardation, 1: 25–40
Nyhan, W. L., Page, T., Gruber, H. E. & Parkman, R. (1986a). Bone marrow transplantation in Lesch–Nyhan disease. In Birth Defects Original Article Series, 22: 113–117
Nyhan, W. L., Parkman, R., Page, T. et al. (1986b). Bone marrow transplantation in Lesch–Nyhan disease. In Purine and Pyrimidine Metabolism in Man V. Part A: Clinical Aspects Including Molecular Genetics, Advances in Experimental Medicine and Biology, Vol. 195A., ed. W. L. Nyhan, L. F. Thompson & R. W. E. Watts, pp. 167–170. New York: Plenum Press
Ogasawara, N., Stout, J. T., Gota, H. et al. (1989). Molecular analysis of a female Lesch–Nyhan patient. Journal of Clinical Investigations, 84: 1024–1027
Page, T. & Broock, R. L. (1990). A pitfall in the prenatal diagnosis of Lesch–Nyhan syndrome by chorionic villus sampling. Prenatal Diagnosis, 10: 153–157
Page, T., Bakay, B., Nissinen, E. & Nyhan, W. L. (1981). Hypoxanthine–guanine phosphoribosyltransferase variants: correlation of clinical phenotype with enzyme activity. Journal of Inherited Metabolic Disease, 4: 203–206
Page, T., Bakay, B. & Nyhan, W. L. (1982a). Kinetic studies of normal and variant hypoxanthine phospho-ribosyltransferases in intact fibroblasts. Annals of Biochemistry, 122: 144–147
Page, T., Bakay, B. & Nyhan, W. L. (1982b). An improved procedure for detection of hypoxanthine–guanine phosphoribosyltransferase heterozygotes. Clinical Chemistry, 28: 1181–1184
Page, T., Broock, R. L., Nyhan, W. L. & Nieto, L. H. (1986). Use of selective media for distinguishing variant forms of hypoxanthine phosphoribosyl transferase. Clinica Chimica Acta, 154: 195–202
Page, T., Nyhan, W. L. & Morena de Vega, V. (1987). Syndrome of mild mental retardation, spastic gait, and skeletal malformations in a family with partial deficiency of hypoxanthineguanine phosphoribosyltransferase. Pediatrics, 79: 713–717
Patel, P. I., Framson, P. E., Caskey, C. T. & Chinault, A. C. (1986). Fine structure of the human hypoxanthine phosphoribosyltransferase gene. Molecular and Cell Biology, 6: 393–403
Rosenbloom, F. M., Kelley, W. N., Miller, J. et al. (1967). Inherited disorder of purine metabolism: correlation between central nervous system dysfunction and biochemical defects. Journal of the American Medical Association, 202: 195–197
Seegmiller, J. E., Rosenbloom, F. M. & Kelley, W. N. (1967). Enzyme defect associated with sex-linked human neurological disorder and excessive purine synthesis. Science, 155: 1682–1684
Sege-Peterson, K., Chambers, J., Page, T. et al. (1992a). Characterization of mutations in phenotypic variants of hypoxanthine–guanine phosphoribosyltransferase deficiency. Human Molecular Genetics, 1: 427–432
Sege-Peterson, K., Nyhan, W. L. & Page, T. (1992b). Lesch–Nyhan disease and HPRT deficiency. In The Molecular and Genetic Basis of Neurological Disease, ed. R. N. Rosenberg, S. B. Prusiner, S. DiMauro, R. L. Barchi & L. M. Kunkel, pp. 241–259. Stoneham, MA: Butterworth-Heinemann
Shapira, J., Zilberman, Y. & Becker, A. (1985). Lesch–Nyhan syndrome: a nonextracting approach to prevent mutilation. Special Care in Dentistry, 210–212
Shear, C. S., Nyhan, W. L., Kirman, B. H. & Stern, J. (1971). Self-mutilative behavior as a feature of the De Lange syndrome. Journal of Pediatrics, 78: 506–509
Silverstein, F. S., Johnston, M. V., Hutchinson, R. J. & Edwards, N. L. (1985). Lesch–Nyhan syndrome: CSF neurotransmitter abnormalities. Neurology, 35: 907–911
Sweetman, L. (1968). Urinary and cerebrospinal fluid oxypurine levels and allopurinol metabolism in the Lesch–Nyhan syndrome. Federation Proceedings, 27: 1055–1059
Sweetman, L., Borden, M., Kulovich, S., Kaufman, I. & Nyhan, W. L. (1977a). Altered excretion of 5-hydroxyindoleacetic acid and glycine in patients with the Lesch–Nyhan disease. In Purine Metabolism in Man II: Regulation of Pathways and Enzyme Defects, ed. M. M. Muller, E. Kaiser & J. E. Seegmiller, pp. 398–404. New York: Plenum Publishing Corp
Sweetman, L., Borden, M., Lesh, P. et al. (1977b). Diminished affinity for purine substrates as a basis for gout with mild deficiency of hypoxanthine guanine phosphoribosyl transferase. In Purine Metabolism in Man: II. Regulation of Pathways and Enzyme Defects, ed. M. M. Muller, E. Kaiser & J. E. Seegmiller, pp. 329–325. New York: Plenum Press
Sweetman, L., Hoch, M. A., Bakay, B. et al. (1978). A distinct human variant of hypoxanthine–guanine phospho-ribosyltransferase. Journal of Pediatrics, 92: 385–389
Tarle, S. A., Davidson, B. L., Wu, V. C. et al. (1991). Determination of the mutations responsible for the Lesch–Nyhan syndrome in 17 subjects. Genomics, 10: 499–501
Watts, R. W. E., Spellacy, E., Gibbs, D. A. et al. (1982). Clinical, post-mortem, biochemical and therapeutic observations on the Lesch–Nyhan syndrome with particular reference to the neurological manifestations. Quarterly Journal of Medicine, 201: 43–78
Willis, R., Jolly, D. J., Miller, A. D. et al. (1984). Partial phenotypic correction of human Lesch–Nyhan (hypoxanthine–guanine phosphoribosyltransferase deficient) lymphoblasts with a transmissible retroviral vector. Journal of Biological Chemistry, 259: 7842–7849
Wilson, J. M., Tarr, G. E., Mahoney, W. C. & Kelley, W. N. (1982). Human hypoxanthine–guanine phosphoribosyl-transferase. Complete amino acid sequence of the erythrocytes enzyme. Journal of Biological Chemistry, 257: 10978–10985
Wong, D. F., Harris, J. C., Naidu, S. et al (1996). Dopamine transporters are markedly reduced in Lesch–Nyhan disease in vivo. Proceedings of the National Academy of Sciences, USA, 93: 6639–6643
Wurtele, S. K., King, A. C. & Drabman, R. S. (1984). Treatment package to reduce self-injurious behavior in a Lesch–Nyhan patient. Journal of Mental Deficiency Research, 28: 227–234
Yang, T. P., Patel, P. I., Chinault, A. C. et al. (1984). Molecular evidence for new mutation at the HPRT locus in Lesch–Nyhan patients. Nature, 310: 412–414
Yee, J. K., Moores, J. C., Jolly, D. J. et al. (1987). Gene expression from transcriptionally disabled retroviral vectors. Proceedings of the National Academy of Sciences, USA, 84: 5179–5201
der. Zee, S. P., Schretlen, E. D. & Monnens, L. A. (1968). Megaloblastic anaemia in the Lesch–Nyhan syndrome. Lancet, I: 1427